Silji Abraham compensation by year
WEST PHARMACEUTICAL SERVICES Summary Compensation Table · all 7 fiscal years held| Component | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|---|
| Salary | $339,038 | $421,000 | $440,769 | $469,231 | $500,000 | $520,192 | $539,231 |
| Bonus | $68,333 | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock awards | $599,972 | $240,645 | $400,028 | $330,870 | $300,103 | $350,229 | $400,256 |
| Option awards | $199,985 | $200,002 | $399,968 | $274,932 | $299,922 | $349,901 | $400,116 |
| Non-equity incentive | $241,552 | $340,388 | $545,815 | $570,261 | $164,775 | $414,619 | $0 |
| Pension and deferred compensation | $0 | $0 | $0 | $0 | $0 | $0 | — |
| All other | $42,640 | $35,104 | $42,010 | $68,917 | $47,126 | $37,281 | $45,381 |
| Total | $1,491,520 | $1,237,139 | $1,828,589 | $1,714,211 | $1,307,119 | $1,672,222 | $1,384,984 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: WEST PHARMACEUTICAL SERVICES INC DEF 14A filed March 21, 2025, accession 0001558370-25-003461, and prior-year filings.
How this page was built: the WEST PHARMACEUTICAL SERVICES INC filed document, accession 0001558370-25-003461. Every figure is read from that document and cited to the page and table it appears in. Filed March 21, 2025.
Equity holdings
unvested awards at FY2024 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| PSU | 2,292 | $750,684 | — |
| Option | 1,554 | — | $369.13 |
| Option | 2,968 | — | $350.18 |
| Option | 2,412 | — | $306.68 |
| Option | 1,091 | — | $274.29 |
Per the Outstanding Equity Awards at Fiscal Year-End table in WEST PHARMACEUTICAL SERVICES INC's FY2024 proxy; value at the fiscal year-end close, as the company printed it.
WEST PHARMACEUTICAL SERVICES’s named executive officers, FY2024
as the company reported each| Named executive officer | Role | FY2024 total |
|---|---|---|
| Eric Green | President and CEO, Chair of Board | $8,394,201 |
| Bernard Birkett | SVP, Chief Financial Officer | $3,137,579 |
| Silji Abraham · this page | SVP, Chief Technology Officer | $1,384,984 |
| Annette Favorite | SVP, Chief Human Resources Officer | $1,248,372 |
| Kimberly MacKay | SVP, General Counsel and Secretary | $1,234,050 |
The full WEST PHARMACEUTICAL SERVICES compensation record
free company briefThis page is one person within WEST PHARMACEUTICAL SERVICES's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the WEST PHARMACEUTICAL SERVICES proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are WEST PHARMACEUTICAL SERVICES's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.